Ibraheem, I.B.M.; Alharbi, R.M.; Abdel-Raouf, N.; Al-Enazi, N.M.; Alsamhary, K.I.; Ali, H.M.
Algal Metabolites as Novel Therapeutics Against Methicillin-Resistant Staphylococcus aureus (MRSA): A Review. Pharmaceutics 2025, 17, 989.
https://doi.org/10.3390/pharmaceutics17080989
AMA Style
Ibraheem IBM, Alharbi RM, Abdel-Raouf N, Al-Enazi NM, Alsamhary KI, Ali HM.
Algal Metabolites as Novel Therapeutics Against Methicillin-Resistant Staphylococcus aureus (MRSA): A Review. Pharmaceutics. 2025; 17(8):989.
https://doi.org/10.3390/pharmaceutics17080989
Chicago/Turabian Style
Ibraheem, Ibraheem Borie M., Reem Mohammed Alharbi, Neveen Abdel-Raouf, Nouf Mohammad Al-Enazi, Khawla Ibrahim Alsamhary, and Hager Mohammed Ali.
2025. "Algal Metabolites as Novel Therapeutics Against Methicillin-Resistant Staphylococcus aureus (MRSA): A Review" Pharmaceutics 17, no. 8: 989.
https://doi.org/10.3390/pharmaceutics17080989
APA Style
Ibraheem, I. B. M., Alharbi, R. M., Abdel-Raouf, N., Al-Enazi, N. M., Alsamhary, K. I., & Ali, H. M.
(2025). Algal Metabolites as Novel Therapeutics Against Methicillin-Resistant Staphylococcus aureus (MRSA): A Review. Pharmaceutics, 17(8), 989.
https://doi.org/10.3390/pharmaceutics17080989